Delivery Order SPE2DB22D1017-SPE2DB25FG2PZ
- Not listed
- The Defense Logistics Agency awarded a $24,229.80 delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 tablets per unit. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of June 2, 2025. The contract specifies AmerisourceBergen's Conshohocken, Pennsylvania location as the place of performance. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $7,383.45 delivery order to AmerisourceBergen Drug Corp for Biktarvy 50-200-25 mg tablets (30-count packaging) on September 18, 2025, with an ultimate completion date of September 19, 2025. This firm fixed-price contract is non-set-aside and represents a competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child delivery order, this award falls under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,248.66 on May 16, 2025, for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed price, non-set-aside contract with an ultimate completion date of May 19, 2025, and performance to be executed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $26,362.04 to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Biktarvy 50-200-25 mg tablets (30-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 28, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $66,413.01 on September 16, 2025, for the supply of Biktarvy 50-200-25 mg tablets (30-count units). This firm fixed-price, non-competitive set-aside contract is scheduled for completion by September 17, 2025, with performance at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $159,128.18 firm fixed-price delivery order to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 mg tablets (30-count units) with an ultimate completion date of September 15, 2025. This competitively awarded, non-set-aside contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order valued at $53,908.10 to AmerisourceBergen Drug Corp for Biktarvy 50-200-25 mg tablets (30-count units) on August 6, 2025, with an ultimate completion date of August 7, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract for pharmaceutical supply to support federal medical procurement needs. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a $35,074.07 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. The contract is non-set-aside and competitively awarded, with an ultimate completion date of August 13, 2025. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $62,141.14 firm fixed-price delivery order to AmerisourceBergen Drug Corp on April 23, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. The contract, which is classified as a child contract with no set-aside designation, reflects a competitively awarded transaction and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania, with an ultimate completion date of April 24, 2025. This delivery order draws...
- The Defense Logistics Agency awarded a $57,995.91 delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Biktarvy 50-200-25 mg tablets (30-count units), with an ultimate completion date of August 28, 2025. This contract employs firm fixed pricing and carries no set-aside designation, reflecting competitive procurement through open competition. The order is issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FG2PZDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $17,036.18 for Biktarvy 50-200-25 mg tablets (30-count units) on May 14, 2025, with completion scheduled for May 15, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order falls within AmerisourceBergen's comprehensive pharmaceutical supply agreement with the Defense Logistics Agency, which enables the company to deliver a broad range of medications and medical supplies supporting military healthcare systems globally. As a major pharmaceutical distributor, AmerisourceBergen fulfills critical medical procurement needs for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare entities. The Biktarvy tablets being supplied are an antiretroviral medication used in HIV treatment, consistent with AmerisourceBergen's demonstrated portfolio of specialized pharmaceutical products serving federal medical supply requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.0k | 5/14/25 |